The development of the physicochemical characteristics of the new original nootropic substance TST-9

   
Brkich G.E.1, Pyatigorskaya N.V.1, Beregovykh V.V.1, Zyryanov O.A.1 , Demina N.B.1, Bakrushina E.O.1

1. I.M. Sechenov First Moscow State Medical University, Moscow, Russia
Section: Experimental Study
DOI: 10.18097/PBMC20206603257      PubMed Id: 32588832
Year: 2020  Volume: 66  Issue: 3  Pages: 257-264
Physicochemical properties of the original pharmaceutical substance TST-9 based on the 3,7-diazabicyclo[3.3.1]nonane derivative with the chemical name IUPAC 6-[4methoxy-3-(1H-pyrazol-1-ylmethyl) benzyl]-1,11-dimethyl-3,6,9-triazatricyclo[7.3.1.1]tetradecane-4,8,12-trion, were studied. TST-9 is used as an active substance for the development of the composition and technology for the preparation of an innovative oral drug. The pharmaceutical substance TST-9 is an amorphous white powder, odorless, soluble in chloroform, acetonitrile, methylene chloride, acetone, dimethyl sulfoxide, dimethylformamide and alcohol, sparingly soluble in diethyl ether, dioxane and is very slightly soluble in water, hexane, and heptane. The melting point ranged from 94°C to 96°C without visible decomposition of the substance. The microbiological purity corresponds to category 2.2. Residual organic solvents in the form of chloroform did not exceed 0.006%. The amount of impurities was not more than 0.15%. The loss in mass upon drying was not more than 0.5%. The “identity” was confirmed using nuclear magnetic resonance spectroscopy and HPLC with UV detection. The data obtained in the study will contribute to the further development of the dosage form, the choice of the route of administration and the dosage regimen, as well as the selection of analytical methods for analyzing the quality of the finished dosage form and the effective, high-precision determination of the content of the active substance and its likely decay products.
Download PDF:
Keywords: TST-9, pharmaceutical substance, physicochemical properties, 3,7-diazabicyclononane derivative, pharmaceutical development
Citation:

Brkich, G. E., Pyatigorskaya, N. V., Beregovykh, V. V., Zyryanov, O. A., Demina, N. B., Bakrushina, E. O. (2020). The development of the physicochemical characteristics of the new original nootropic substance TST-9. Biomeditsinskaya khimiya, 66(3), 257-264.
References  
 2020 (vol 66)
 2019 (vol 65)
 2018 (vol 64)
 2017 (vol 63)
 2016 (vol 62)
 2015 (vol 61)
 2014 (vol 60)
 2013 (vol 59)
 2012 (vol 58)
 2011 (vol 57)
 2010 (vol 56)
 2009 (vol 55)
 2008 (vol 54)
 2007 (vol 53)
 2006 (vol 52)
 2005 (vol 51)
 2004 (vol 50)
 2003 (vol 49)